Citation: K. Taxis et al., Hospital drug distribution systems in the UK and Germany - a study of medication errors, PHARM WORLD, 21(1), 1999, pp. 25-31
Authors:
Dean, B
Tomaskovic-Crook, E
Opeskin, K
Keks, N
Copolov, D
Citation: B. Dean et al., No change in the density of the serotonin(1A) receptor, the serotonin(4) receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia, NEUROCHEM I, 34(2), 1999, pp. 109-115
Citation: Jm. Crook et al., The binding of [H-3]AF-DX 384 is reduced in the Caudate-Putamen of subjects with schizophrenia, LIFE SCI, 64(19), 1999, pp. 1761-1771
Authors:
Dean, B
Hussain, T
Hayes, W
Scarr, E
Kitsoulis, S
Hill, C
Opeskin, K
Copolov, DL
Citation: B. Dean et al., Changes in serotonin(2A) and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex, J NEUROCHEM, 72(4), 1999, pp. 1593-1599
Authors:
Kouzmenko, AP
Scaffidi, A
Pereira, AM
Hayes, WL
Copolov, DL
Dean, B
Citation: Ap. Kouzmenko et al., No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia, HUMAN HERED, 49(2), 1999, pp. 103-105
Citation: B. Dean et al., Decreased Serotonin(2A) receptors in Brodmann's area 9 from schizophrenic subjects - A pathological or pharmacological phenomenon?, MOL CHEM NE, 34(2-3), 1998, pp. 133-145
Citation: B. Dean, Plasma homovanillic acid (HVA) in schizophrenia: implications for presynaptic dopamine dysfunction, AUST NZ J P, 32(6), 1998, pp. 895-895